百奥赛图（北京）医药科技股份有限公司2026年第一次临时股东会决议公告

Group 1 - The core point of the announcement is the resolution of the first extraordinary general meeting of shareholders held by Bai Ao Sai Tu (Beijing) Pharmaceutical Technology Co., Ltd. on February 12, 2026, confirming that there were no rejected proposals [1][2]. - The meeting was convened by the board of directors and chaired by Chairman Shen Yuelai, utilizing a combination of on-site and online voting methods for A-share shareholders [2][3]. - All eight current directors and the board secretary attended the meeting, along with other senior management personnel [3]. Group 2 - The main agenda item was the election of a non-executive director for the second board of directors, which was approved by a majority of the voting shareholders [4]. - The voting results indicated that the proposals were passed with more than half of the valid voting rights held by attending shareholders, and separate counting was conducted for small and medium A-share investors [5]. - The meeting was witnessed by Beijing Zhonglun Law Firm, confirming that the procedures and voting results complied with relevant laws and regulations [5].